ProteostaSys: a systems view of proteostasis

08 - 09 September 2025 08:45 - 17:00 Hilton Cambridge City Centre Free
Request an invitation

Theo Murphy meeting organised by Dr Ritwick Sawarkar, Professor Rick Morimoto, Professor Lea Sistonen, and Dr Anat Ben-Zvi.

Proteostasis underpins the homeostasis of the functional proteome and is implicated in most age-related disease conditions. The proposed meeting will capitalise on the recent definition of the human proteostasis network to bring together experts from molecular cell biology and quantitative systems biology. The meeting will facilitate interdisciplinary discussions and proteostasis to speed up fundamental discoveries with biomedical implications.

Programme

The programme, including the speaker biographies and abstracts, will be available soon.

Attending this event

  • Free to attend and in-person only
  • When requesting an invitation, please briefly state your expertise and reasons for attending
  • Requests are reviewed by the meeting organisers on a rolling basis. You will receive a link to register if your request has been successful
  • Catering options will be available to purchase upon registering. Participants are responsible for booking their own accommodation. Please do not book accommodation until you have been invited to attend the meeting by the meeting organisers

Enquiries: contact the Scientific Programmes team

Schedule

Chair

Dr Laura Itzhaki, University of Cambridge, UK

Dr Laura Itzhaki, University of Cambridge, UK

10:10-10:30 Discussion
10:30-11:00 Break
11:40-12:00 Impaired sphingolipid homeostasis exacerbates tau pathology by disrupting endolysosomal integrity through endomembrane rigidification

The progression of neurodegenerative diseases such as Alzheimer’s disease (AD) or Parkinson’s disease (PD), is linked to the spreading of protein aggregation across interconnected brain regions. Fibrillar seeds are transferred between cells, inducing misfolding and aggregation of its native monomeric counterpart. A critical rate-limiting step in this process is the rupture of endolysosomal vesicles, which releases transferred aggregates into the cytosol, where they promote further aggregation of endogenous proteins. While the pathways underlying endolysosomal damage and repair have been increasingly studied, many aspects remain unclear. We conducted a genome-wide RNAi screen in a novel C. elegans model of tau spreading and identified sphingolipid metabolism genes as critical for endolysosomal integrity. Using C. elegans and cell culture models, we investigated how disruption of sphingolipid homeostasis affects endolysosomal membrane integrity and contributes to tau aggregation and toxicity. Fluorescence recovery after photobleaching and C-Laurdan dye imaging revealed that silencing sphingolipid metabolism genes decreases endolysosomal vesicle membrane fluidity, increasing endolysosomal rupture. The accumulation of aggregated tau in endolysosomal vesicles further aggravated endomembrane rigidification and damage and promoted seeded tau aggregation, potentially by facilitating the escape of tau seeds from the endolysosomal system. Supplementation with unsaturated fatty acids improved membrane fluidity, suppressing endolysosomal rupture and seeded tau aggregation in cell models, and alleviating tau-associated neurotoxicity in C. elegans. Conversely, supplementation with the saturated fatty acid palmitic acid worsened these effects. These findings provide insights into how impaired sphingolipid homeostasis drives tau pathology, suggesting membrane fluidity restoration as a potential therapeutic strategy for AD.

Professor Carmen Nussbaum

Professor Carmen Nussbaum

Ludwig Maximilians University Munich, Germany

13:50-14:10 Intersections between protein oxidation-reduction pathways and proteostasis at the subcellular level 

Protein disulfide formation contributes to protein folding and function, as evidenced by numerous oxidoreductases that maintain disulfide status within various cell compartments.  Many of these oxidoreductases, including thioredoxins (Trxs) and protein disulfide isomerases (PDIs), arose from a common evolutionary precursor and employ transient thiol-disulfide exchange mechanisms when interacting with their redox partners.  Because disulfide bonds that form between Trx superfamily members and their redox partners are often short-lived, we developed a chemical cross-linking strategy that irreversibly captures these proteins when interacting with potential redox partners.  Using the thiol-reactive cross-linker divinyl sulfone (DVSF), Trx2, a cytosolic Trx in baker’s yeast, undergoes cross-linking with its most prominent redox partners via modification of its active site cysteines. Likewise, upon DVSF treatment, PDIs that promote oxidative protein folding in the ER form cross-linked complexes with known redox partners, including many chaperones and protein clearance factors. More recently, we have turned our attention to less studied redox networks, seeking to identify the interaction partners of disulfide maintenance systems in mitochondria.  Particularly, we have characterised the putative redox partners of yeast Trx3, a disulfide reductase that resides in the mitochondrial matrix. We have found that Trx3 interacts with numerous metabolic enzymes, including members of the branched chain amino acid biosynthesis pathway, as well as proteins in the proteostasis network.  Our current work suggests disulfide bond homeostasis and flux through specific metabolic pathways may be linked in previously undescribed ways.

Professor James West

Professor James West

The College of Wooster, USA